KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $467.2 million.

  • Cme's Other Operating Expenses rose 38.68% to $467.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year increase of 132.19%. This contributed to the annual value of $1.9 billion for FY2024, which is 95.09% up from last year.
  • As of Q3 2025, Cme's Other Operating Expenses stood at $467.2 million, which was up 38.68% from $464.5 million recorded in Q2 2025.
  • Cme's 5-year Other Operating Expenses high stood at $517.6 million for Q4 2023, and its period low was $407.7 million during Q3 2022.
  • Over the past 5 years, Cme's median Other Operating Expenses value was $441.3 million (recorded in 2025), while the average stood at $448.0 million.
  • In the last 5 years, Cme's Other Operating Expenses plummeted by 1243.86% in 2021 and then skyrocketed by 896.84% in 2023.
  • Cme's Other Operating Expenses (Quarter) stood at $469.8 million in 2021, then grew by 4.19% to $489.5 million in 2022, then grew by 5.74% to $517.6 million in 2023, then dropped by 0.99% to $512.5 million in 2024, then dropped by 8.84% to $467.2 million in 2025.
  • Its last three reported values are $467.2 million in Q3 2025, $464.5 million for Q2 2025, and $441.3 million during Q1 2025.